Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)

Por Robb, Caroline M, Contreras, Jacob I, Kour, Smit, Taylor, Margaret A, Abid, Mohammad, Sonawane, Yogesh A, Zahid, Muhammad, Murry, Daryl J, Natarajan, Amarnath, Rana, Sandeep
Publicado no Chem Commun (Camb) (2017)

Chemical Genetic Screens Identify Kinase Inhibitor Combinations that Target Anti-Apoptotic Proteins for Cancer Therapy

Por Contreras, Jacob I., Robb, Caroline M., King, Hannah M., Baxter, Jared, Crawford, Ayrianne J., Kour, Smit, Kizhake, Smitha, Sonawane, Yogesh A., Rana, Sandeep, Hollingsworth, Michael A., Luo, Xu, Natarajan, Amarnath
Publicado no ACS Chem Biol (2018)

Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy

Por Robb, Caroline M., Kour, Smit, Contreras, Jacob I., Agarwal, Ekta, Barger, Carter J., Rana, Sandeep, Sonawane, Yogesh, Neilsen, Beth K., Taylor, Margaret, Kizhake, Smitha, Thakare, Rhishikesh N., Chowdhury, Sanjib, Wang, Jing, Black, Jennifer D., Hollingsworth, Michael A., Brattain, Michael G., Natarajan, Amarnath
Publicado no Oncotarget (2017)